Stem, Inc. STEM
2.37 USD +0.12 (+5.33%)
Nov 3, 2026, 3:47 PM EST
2.29 Day range 2.41
2.15 52-week range 22.12
- YTD
- -84.25%
- 1 year
- -87.52%
Analyst view
Consensus: hold
Hold
Price target (mean) 1.88 -20.9% downside
Now 2.37
- Target (low)
- 0.30
- Target (mean)
- 1.88
- Target (high)
- 11.00
Ratings (0m) 14 3 buy · 11 hold · 0 sell
- Strong buy0
- Buy3
- Hold11
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 15
- 2 months ago 15
- 3 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.1632 | -0.23 – -0.09 | -0.2067 | +21.0% | 49.19M | -70.6% | 4 |
| Next quarter | -0.14309 | -0.201 – -0.02 | -0.2413 | +40.7% | 67.77M | +166.1% | 4 |
| Current year | -1.18 | -1.82 – -0.79 | -0.94309 | -25.4% | 136.00M | -70.5% | 4 |
| Next year | -0.49546 | -0.89 – -0.01 | -1.18 | +58.1% | 381.42M | +180.4% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 22, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Nov 8, 2024 | UBS | Maintained | Buy | Buy |
| Nov 1, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Oct 18, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 16, 2024 | Susquehanna | Maintained | Neutral | Neutral |
| Aug 9, 2024 | Susquehanna | Downgrade | Positive | Neutral |
| Aug 8, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 8, 2024 | UBS | Maintained | Buy | Buy |
| Aug 7, 2024 | TD Cowen | Downgrade | Buy | Hold |
| Aug 7, 2024 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 15, 2024 | Susquehanna | Maintained | Positive | Positive |
| May 8, 2024 | UBS | Maintained | Buy | Buy |
| May 6, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| May 3, 2024 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 3, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Apr 11, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Mar 22, 2024 | Goldman Sachs | Downgrade | Buy | Neutral |
| Feb 29, 2024 | Susquehanna | Maintained | Positive | Positive |
| Feb 29, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Feb 29, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jan 24, 2024 | Goldman Sachs | Maintained | Buy | Buy |
| Dec 8, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 3, 2023 | Guggenheim | Downgrade | Buy | Neutral |
| Nov 2, 2023 | Roth MKM | Maintained | Neutral | Neutral |
| Nov 1, 2023 | Roth MKM | Maintained | Neutral | Neutral |
| Oct 24, 2023 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 20, 2023 | Exane BNP Paribas | Initiated | — | Neutral |
| Oct 17, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 6, 2023 | Piper Sandler | Maintained | Neutral | Neutral |
| Sep 8, 2023 | Evercore ISI Group | Maintained | Outperform | Outperform |